COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,015 Articles (22,627 medRxiv, 8,388 bioRxiv)

Most recent first Previous |  Page 1310: Articles 13091-13100  | Next

Variations in Non-Pharmaceutical Interventions by State Correlate with COVID-19 Disease Outcomes
Avery, A. J., Wang, J., Ma, X., Pan, Q., McGrady, E. E., Yuan, Z., Liang, Y., Nugent, R., Lakdawala, S. S.
10.1101/2021.07.28.21261286 — Posted: 2021-07-31 Discussion: Onsite
Estimates of Single Dose and Full Dose BNT162b2 Vaccine Effectiveness among USAF Academy cadets, 1 Mar - 1 May 2021
Wickert, D. P., Almand, E., Cullenbine, C. A., Huckstep, O. J., Rohrer, J., Sitko, J. C., Steel, J. J., Hasstedt, S.
10.1101/2021.07.28.21261138 — Posted: 2021-07-31
Monitoring COVID-19 spread in Prague local neighborhoods based on the presence of SARS-CoV-2 RNA in wastewater collected throughout the sewer network
Zdenkova, K., Bartackova, J., Cermakova, E., Demnerova, K., Dostalkova, A., Janda, V., Novakova, Z., Rumlova, M., Rihova Ambrozova, J., Skodakova, K., Swierczkova, I., Sykora, P., Vejmelkova, D., Wanner, J., Bartacek, J.
10.1101/2021.07.28.21261272 — Posted: 2021-07-31
Individual Preparedness for Distant Wildfires and the Delta Variant in the United States: A Survey of 2,250 US Residents
Srikrishna, D.
10.1101/2021.07.24.21260660 — Posted: 2021-07-31
DERIVATION AND VALIDATION OF A CLINICAL SCORE TO PREDICT DEATH AMONG NON-PALLIATIVE COVID-19 PATIENTS PRESENTING TO EMERGENCY DEPARTMENTS: THE CCEDRRN COVID MORTALITY SCORE
Hohl, C. M., Rosychuk, R. J., Archambault, P. M., O'Sullivan, F., Leeies, M., Mercier, E., Clark, G., Innes, G. D., Brooks, S. C., Hayward, J., Ho, V., Jelic, T., Welsford, M., Sivilotti, M. L., Morrison, L. J., Perry, J. J., Canadian COVID-19 Emergency Department Rapid Response Network
10.1101/2021.07.28.21261283 — Posted: 2021-07-31
Clinical Determinants and Predictors for Prognosis of SARS-CoV-2 Infected Pediatric Patients in Saudi Arabia
Mohamed Adam, K., Elamin, B. K., Al-Faifi, J. A., Abbas, M.
10.1101/2021.07.28.21261284 — Posted: 2021-07-31
An Oral SARS-CoV-2 Mpro Inhibitor Clinical Candidate for the Treatment of COVID-19
Owen, D. R., Allerton, C. M. N., Anderson, A. S., Aschenbrenner, L., Avery, M., Berritt, S., Boras, B., Cardin, R. D., Carlo, A., Coffman, K., Dantonio, A., Di, L., Eng, H., Ferre, R., Gajiwala, K. S., Gibson, S. A., Greasley, S. E., Hurst, B. L., Kadar, E. P., Kalgutkar, A. S., Lee, J. C., Lee, J., Liu, W., Mason, S. W., Noell, S., Novak, J. J., Obach, R. S., Ogilvie, K., Patel, N. C., Pettersson, M., Rai, D. K., Reese, M. R., Sammons, M. F., Sathish, J. G., Singh, R. S. P., Steppan, C. M., Stewart, A. E., Tuttle, J. B., Updyke, L., Verhoest, P. R., Wei, L., Yang, Q., Zhu, Y.
10.1101/2021.07.28.21261232 — Posted: 2021-07-31
Impact of B.1.351 (beta) SARS-CoV-2 variant on BNT162b2 mRNA vaccine effectiveness in long-term care facilities of eastern France: a retrospective cohort study
Lefevre, B., Tondeur, L., Madec, Y., Grant, R., Lina, B., van der Werf, S., Rabaud, C., Fontanet, A.
10.1101/2021.07.28.21261285 — Posted: 2021-07-31
Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant
Riemersma, K. K., Grogan, B. E., Kita-Yarbro, A., Jeppson, G. E., O'Connor, D. H., Friedrich, T. C., Grande, K. M.
10.1101/2021.07.31.21261387 — Posted: 2021-07-31 Discussion: Onsite | Offsite
Staffing and Capacity Planning for SARS-CoV-2 Monoclonal Antibody Infusion Facilities: A Performance Estimation Calculator based on Discrete-Event Simulations
Caglayan, C., Thornhill, J., Stewart, M. A., Lambrou, A. S., Richardson, D., Rainwater-Lovett, K., Freeman, J. D., Pfundt, T., Redd, J. T.
10.1101/2021.07.23.21260984 — Posted: 2021-07-31

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).